Short answer
Elevance Health (ELV) filed an 8-K current report with the SEC on September 10, 2026 reporting Item 7.01 (Regulation FD Disclosure). Reaffirmed FY2026 shareholders’ earnings guidance of at least $20.10 per diluted share.
Elevance Health 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Reaffirmed FY2026 shareholders’ earnings guidance of at least $20.10 per diluted share
- Adjusted FY2026 earnings guidance remains at least $27.00 per diluted share, excluding approximately $6.90 of unfavorable items
- Reaffirmed FY2026 benefit expense ratio guidance of 90.2%, plus or minus 50 basis points
- Guidance stability supports near-term earnings visibility, while benefit-cost performance remains the key operating sensitivity
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Elevance Health 8-K filings
Get the next ELV 8-K as it lands
Follow ELV for push alerts, or ask the research agent what this filing means.